Medical Technology for healthcare professionals
Global website (English)
back
Medical Technology
recommended searches
popular searches
ZEISS CT LUCIA intuitive injector handling

Consistent visual outcomes1

ZEISS CT LUCIA 621P/PY
Receive more information

The sophisticated and patented ZEISS Optic (ZO) Asphericity Concept of the ZEISS CT LUCIA 621P/PY is designed to compensate for a wide range of aberrations due to different corneal shapes and lens positions. With its uniquely forgiving design it delivers excellent visual outcomes for a broad range of patients and surgical situations.

  • Third-party Content Blocked

    The video player is blocked due to your tracking preferences. To change the settings and play the video, please click the button below and consent to use of "Functional" tracking technologies.

Get more information now!

Your ZEISS representative will be in contact with you.

Form is loading...

/ 4
Next Step:
  • Step 1
  • Step 2
  • Step 3
Step 1
Step 2
Step 3

If you want to have more information on data processing at ZEISS please refer to our data privacy notice.

  • Slit lamp examination

    Slit lamp examination showing that the pupil and the IOL are not aligned.
  • Picture showing that the IOL is not centered in the middle of the pupil.

    Picture showing that the IOL is not centered in the middle of the pupil.

Does decentration matter?

Yes! Decentrations of varying magnitude are not uncommon. Besides the asymmetry of the eye, decentration of IOLs can occur due to poor capsular or zonular support, decentered capsulorhexis, asymmetric shrinkage of the capsular bag, misplacement of the haptics for IOL luxation in eyes with pseudoexfoliation. ZEISS CT LUCIA 621P/PY IOLs, with ZEISS optic features, are designed to compensate for potential decentration and lens misalignments. Reducing the risk of decentration allows you more time to focus on your patients and their needs.

Dr. Andreas Borkenstein

The LUCIA lens has some special features […] you have the ZO Optic [ZO: ZEISS Optic], which compared to other aspheric lenses makes the lens more forgiving or less sensitive when it comes to decentration […] And therefore, we use this lens a lot, not only in challenging cases, when you expect, for example, phimosis or capsular shrinkage like pseudoexfoliation syndrome or after uveitis or traumatic cases, but also in standard cases.

Dr. Andreas Borkenstein, MD

Borkenstein & Borkenstein, Graz / Austria

Third-party Content Blocked

The video player is blocked due to your tracking preferences. To change the settings and play the video, please click the button below and consent to use of "Functional" tracking technologies.

Your drylab experience with ZEISS CT LUCIA 621PY & ZEISS miLOOP

This newly available experience kit has been developed to provide a unique way to discover two products at the same time: ZEISS miLOOP and ZEISS CT LUCIA 621PY.

After registration your local ZEISS representative will be in touch to arrange a convenient date to demo the kit either digital or in person.

Please note: The ZEISS CT LUCIA & ZEISS miLOOP drylab kit demo session is only available in the following countries: Austria, Denmark, Finland, France, Italy, Norway, Portugal, South Africa, Spain, Sweden.

  

  • CT LUCIA 621 injector handling

    CT LUCIA® 621P/PY

    CT LUCIA® 621P/PY is the recently enhanced monofocal, hydrophobic, C-Loop IOL from ZEISS, which allows you to treat a wide range of patients with a unique ZEISS Optic, featuring:

    • Consistent visual outcomes¹
    • Excellent stability
    • Intuitive injector handling
  • ZEISS miLOOP

    miLOOP® from ZEISS

    The miLOOP® from ZEISS is a game-changing microinterventional lens fragmentation device, which is designed to remove the challenges of hard cataracts.

    • Reduced phaco energy and fluid use²
    • Minimal stress to capsule and zonules²
    • Reduced procedure and post-op treatment time²⁻³
ZEISS CT LUCIA 621

ZEISS CT LUCIA 621P/PY

  • 1

    The data is taken from a simulation. The transferability of the results of such a simulation to patients with an actual implanted intraocular lenses has not yet been scientifically proven. Whether the simulated impressions correspond to the actual visual impressions must be clarified in future invasive studies.